Managing Comorbid Attention Deficit Hyperactivity Disorder (ADHD) in Adults With Substance Use Disorder (SUD): What the Addiction Specialist Needs to Know

被引:1
|
作者
Johnson, Joe [1 ]
Morris, Sarah [2 ]
George, Sanju [3 ]
机构
[1] Hollins Pk Hosp, North West Boroughs Partnership NHS Fdn Trust, North West Lead UKAAN UK Adult ADHD Network, NW Boroughs Adult ADHD Serv, Liverpool, Merseyside, England
[2] Hollins Pk Hosp, North West Boroughs Healthcare NHS Fdn Trust, Liverpool, Merseyside, England
[3] Rajagiri Coll Social Sci Autonomous, Rajagiri Sch Behav Sci & Res, Kochi 683104, Kerala, India
来源
ADDICTIVE DISORDERS & THEIR TREATMENT | 2021年 / 20卷 / 03期
关键词
attention deficit hyperactivity disorder; substance use disorder; comorbidity; management; DEFICIT/HYPERACTIVITY DISORDER; ALCOHOL; MANAGEMENT; SYMPTOMS;
D O I
10.1097/ADT.0000000000000237
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD) often co-exist and the link between the 2 is bidirectional, with higher rates of ADHD symptoms found in the SUD population and higher rates of SUD found among the ADHD population. Some possible mechanisms which could explain the increased risk of developing a SUD in those who have ADHD include self-medication, both ADHD and SUD arising from dysregulation of 1 or more of the dopaminergic circuits, genetic factors as well exposure to parental SUD. Given the complex relationship between ADHD and SUD, those working in SUD services should be vigilant to ADHD as a possible comorbid diagnosis and refer to a specialist ADHD service for further assessment where appropriate. On the basis of a detailed clinical assessment, it has to be decided whether SUD or ADHD should be the priority for treatment or if they both ought to be; in either case, ADHD and SUD treatment services must work collaboratively. The recommended first line pharmacological treatment option for adolescents and adults with ADHD is a stimulant medication, with nonstimulants being reserved as a second or third line option. In the brief review paper, the authors further discuss the various medications for treatment of ADHD, the benefits and risks of treating ADHD in those with SUD, discuss the role of specialist ADHD treatment services, and illustrate these with the help of 2 anonymized case vignettes.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 50 条
  • [21] Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults
    Castells, Xavier
    Antoni Ramos-Quiroga, Josep
    Bosch, Rosa
    Nogueira, Mariana
    Casas, Miguel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (06):
  • [22] Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
    Castells, Xavier
    Blanco-Silvente, Lidia
    Cunill, Ruth
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [23] Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
    Verbeeck, Wim
    Bekkering, Geertruida E.
    Van den Noortgate, Wim
    Kramers, Cornelis
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [24] International Consensus on the screening, diagnosis and treatment of patients with substance use disorders comorbid with attention deficit disorder with or without hyperactivity
    van Kernebeek, Michiel W.
    Vorspan, Florence
    Crunelle, Cleo L.
    van den Brink, Wim
    Dom, Geert
    Moggi, Franz
    Konstenius, Maija
    Franck, Johan
    Levin, Frances R.
    van de Glind, Geurt
    Ramos-Quiroga, Jose A.
    Demetrovics, Zsolt
    Coetzee, Corne
    Luderer, Mathias
    Schellekens, Arnt
    Matthys, Frieda
    Icick, Romain
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2022, 34 (02) : 55 - 67
  • [25] Comorbid attention-deficit hyperactivity disorder and bipolar disorder
    Parker, Gordon
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (06): : 789 - 792
  • [26] Personal Recovery in Individuals Diagnosed with Substance use Disorder (SUD) and Co-Occurring Attention Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
    Kronenberg, Linda M.
    Verkerk-Tamminga, Roeliene
    Goossens, Peter J. J.
    van den Brink, Wirn
    van Achterberg, Theo
    ARCHIVES OF PSYCHIATRIC NURSING, 2015, 29 (04) : 242 - 248
  • [27] Methylphenidate - Therapy option for adults with ADHD and comorbid substance use disorder?
    Paslakis, G.
    Kiefer, F.
    Diehl, A.
    Alm, B.
    Sobanski, E.
    NERVENARZT, 2010, 81 (03): : 277 - +
  • [28] Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): A systematic review
    Taylor, Abigail
    Deb, Shoumitro
    Unwin, Gemma
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2011, 32 (03) : 924 - 938
  • [29] Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults
    Weibel, S.
    Menard, O.
    Ionita, A.
    Boumendjel, M.
    Cabelguen, C.
    Kraemer, C.
    Micoulaud-Franchi, J-A
    Bioulac, S.
    Perroud, N.
    Sauvaget, A.
    Carton, L.
    Gachet, M.
    Lopez, R.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2020, 46 (01): : 30 - 40
  • [30] The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults
    Dobrosavljevic, Maja
    Larsson, Henrik
    Cortese, Samuele
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (10) : 883 - 893